UK Patients Receive First App-Controlled Implants for Sleep Apnoea
New nerve-stimulating devices offer an alternative to traditional CPAP machines, with promising early results for patients.
- University College London HospitalsUK center to offer app-controlled nerve stimulators for sleep apnoea treatment.
- The implants, Genio Nyxoah and Inspire, stimulate the hypoglossal nerve to prevent airway blockages during sleep.
- Patients can control the devices' stimulation levels and monitor sleep patterns via a smartphone app.
- Early results show significant improvements in symptoms, with reduced breathing interruptions and quicker recovery times compared to traditional surgeries.
- Eligibility for the implants requires moderate to severe sleep apnoea, a BMI under 35, and prior unsuccessful CPAP machine use.
ReadWrite 
The Independent 
Metro 
Evening Standard 
The Times 
Sky News 